Skip to main content
Ventripoint Diagnostics Ltd. logo

Ventripoint Diagnostics Ltd. — Investor Relations & Filings

Ticker · VPT ISIN · CA92281P2008 LEI · 529900QV0P93LL6P2M57 TSXV Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 256 across all filing types
Latest filing 2026-04-22 Capital/Financing Update
Country CA Canada
Listing TSXV VPT

About Ventripoint Diagnostics Ltd.

https://ventripoint.com/

Ventripoint Diagnostics Ltd. is a medical device company specializing in AI-driven cardiac imaging solutions. The company's patented technology, embodied in the VMS+ software, transforms standard 2D echocardiograms into high-fidelity 3D models of all four heart chambers. This process provides accurate, reproducible volumetric measurements and ejection fractions, offering diagnostic performance comparable to MRI but with the speed and cost-effectiveness of ultrasound. The VMS+ system is designed to aid in monitoring patients with heart conditions, delivering detailed heart analysis even when using imperfect images or on patients who cannot undergo MRI procedures, such as those with pacemakers.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Capital/Financing Update Classification · 72% confidence The document is a detailed offering document for a structured note issuance by TD Canada Bank, including terms, features, pricing, and maturity provisions. It constitutes a financing activity (raising capital through debt issuance) rather than a simple regulatory notice or dividend announcement. Therefore, it best fits the "Capital/Financing Update" category (CAP).
2026-04-22 English
Form of proxy - English.pdf
Proxy Solicitation & Information Statement Classification · 93% confidence The document is a Form of Proxy solicited by and on behalf of management for the Annual and Special Meeting, including instructions for appointing proxyholders and voting on resolutions. It is clearly part of proxy solicitation materials sent to shareholders to request votes and provide meeting information. This matches the definition of Proxy Solicitation & Information Statement (Code: PSI).
2026-04-21 English
Notice of meeting - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a formal Notice of the Annual and Special Meeting of Shareholders, including details on record dates, proxy voting instructions, notice-and-access procedures, and references to the accompanying Management Information Circular (proxy statement). It is not the annual report or earnings release itself, nor is it a simple announcement of a report. It is clearly materials sent to shareholders to provide information about the meeting and solicit their votes. This aligns with the "Proxy Solicitation & Information Statement" category.
2026-04-21 English
Other.pdf
Proxy Solicitation & Information Statement Classification · 91% confidence The document is a Notice and Access Notification for the 2026 Annual and Special Meeting, providing proxy materials access instructions, meeting details, matters to be voted on, and voting procedures. It solicits shareholder votes and refers to the management information circular. These characteristics match the definition of a Proxy Solicitation & Information Statement (PSI).
2026-04-21 English
Management information circular - English.pdf
Proxy Solicitation & Information Statement Classification · 95% confidence The document is the Notice of Meeting and Management Information Circular prepared in connection with the Annual and Special Meeting of Shareholders, including proxy solicitation details, voting instructions, meeting materials access, and management’s proxy form. This clearly matches the definition for a Proxy Solicitation & Information Statement, as it provides information and requests votes for a shareholder meeting. It is not the actual financial report or an earnings release but rather the materials to solicit proxies. Therefore, it is classified as PSI.
2026-04-21 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release announcing that Ventripoint Diagnostics Ltd. has received a Gold Edison Award for its VMS+ 4.0 technology. It focuses on the recognition of innovation, market readiness, and future potential of the technology. There is no financial data, no discussion of financial results, no regulatory filings, no management or board changes, no voting results, no legal proceedings, no capital or financing updates, and no mention of any report being attached or published. The content is promotional and informational about an award and the company's technology, which fits the profile of a general regulatory announcement or news release rather than a formal financial or regulatory filing. Therefore, the best classification is Regulatory Filings (RNS), which is the fallback category for miscellaneous announcements that do not fit other specific categories.
2026-04-20 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.